- Home
- ENVB vs SGLY Comparison
ENVB vs SGLY Comparison
Compare ENVB & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVB
- SGLY
- Stock Information
- Founded
- ENVB 1994
- SGLY 2001
- Country
- ENVB United States
- SGLY United States
- Employees
- ENVB N/A
- SGLY N/A
- Industry
- ENVB Biotechnology: Pharmaceutical Preparations
- SGLY
- Sector
- ENVB Health Care
- SGLY
- Exchange
- ENVB Nasdaq
- SGLY Nasdaq
- Market Cap
- ENVB 3.0M
- SGLY 3.4M
- IPO Year
- ENVB N/A
- SGLY 2008
- Fundamental
- Price
- ENVB $6.70
- SGLY $0.69
- Analyst Decision
- ENVB Strong Buy
- SGLY
- Analyst Count
- ENVB 1
- SGLY 0
- Target Price
- ENVB $10.00
- SGLY N/A
- AVG Volume (30 Days)
- ENVB 63.7K
- SGLY 314.3K
- Earning Date
- ENVB 11-13-2025
- SGLY 10-14-2025
- Dividend Yield
- ENVB N/A
- SGLY N/A
- EPS Growth
- ENVB N/A
- SGLY N/A
- EPS
- ENVB N/A
- SGLY N/A
- Revenue
- ENVB N/A
- SGLY $1,813,193.00
- Revenue This Year
- ENVB N/A
- SGLY N/A
- Revenue Next Year
- ENVB N/A
- SGLY N/A
- P/E Ratio
- ENVB N/A
- SGLY N/A
- Revenue Growth
- ENVB N/A
- SGLY N/A
- 52 Week Low
- ENVB $6.63
- SGLY $0.54
- 52 Week High
- ENVB $99.00
- SGLY $5.49
- Technical
- Relative Strength Index (RSI)
- ENVB 89.48
- SGLY 36.28
- Support Level
- ENVB $0.59
- SGLY $0.71
- Resistance Level
- ENVB $7.51
- SGLY $0.85
- Average True Range (ATR)
- ENVB 0.17
- SGLY 0.06
- MACD
- ENVB 0.63
- SGLY 0.00
- Stochastic Oscillator
- ENVB 88.33
- SGLY 20.19
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
About SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.